자기 수혈 기기 시장 : 시장 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of autotransfusion devices Market

The global autotransfusion devices market was valued at USD 329.61 million in 2025 and is projected to grow to USD 350.97 million in 2026. The market is expected to reach USD 590.49 million by 2034, registering a CAGR of 6.72% during the forecast period (2026-2034).

North America dominated the global market with a 49.76% share in 2025, driven by the increasing number of cardiovascular and orthopedic surgeries, strong healthcare infrastructure, and established clinical guidelines promoting intraoperative and post-operative autotransfusion practices.

Autotransfusion, also known as a cell saver system, allows patients to receive their own blood during surgery, reducing dependence on donor blood. It eliminates cross-matching requirements, minimizes transfusion reactions, and lowers infection risks. These systems are widely used in cardiovascular, orthopedic, neurological, obstetrics & gynecological, and other major surgical procedures.

Market Dynamics

Market Drivers

Rising Number of Surgical Procedures

The growing prevalence of chronic diseases such as cardiac and neurological disorders has increased the number of major surgical procedures globally. Intraoperative and post-operative cell salvage plays a crucial role in blood conservation strategies.

According to the American Joint Replacement Registry (2023), approximately 3.2 million hip and knee arthroplasty procedures were recorded in the U.S. Rising transplant surgeries further support market growth. In 2023, 46,632 organ transplants were performed in the U.S., reflecting an 8.7% increase from 2022.

Additionally, the expanding geriatric population, which is more susceptible to chronic diseases, is increasing demand for advanced blood management systems during surgeries.

Market Restraints

Growing Preference for Minimally Invasive Surgeries

Minimally invasive procedures are gaining popularity due to shorter hospital stays, lower costs, and reduced blood loss. Since these surgeries involve limited bleeding, the need for autotransfusion devices may decline. Moreover, the development of advanced hemostatic devices further reduces blood loss, limiting the adoption of autotransfusion systems.

Market Opportunities

Gap Between Blood Demand and Supply

The increasing shortage of donor blood in both developed and emerging countries presents a significant opportunity. Although blood supply in China grew by 7.0% over the past decade, surgical procedures increased by 18.0%, creating a supply-demand gap. Autotransfusion systems provide a reliable solution to address this imbalance.

Market Challenges

High product costs and technological complexities may limit adoption in emerging economies. Additionally, the risk of infection in contaminated surgical fields may restrict device usage in certain procedures.

Market Trends

Technological Advancements

Continuous innovation is a key market trend. In September 2022, Atlanpole Biotherapies received CE approval for its i-SEP autotransfusion device capable of recovering both red blood cells and platelets.

In March 2023, Haemonetics Corporation received U.S. FDA clearance for next-generation Intelligent Control software for the Cell Saver Elite+ system, enhancing operational efficiency and user experience.

Segmentation Analysis

By Product Type

The market is segmented into autotransfusion systems and consumables & accessories.

The consumables & accessories segment dominated in 2026 with a 58.10% share, driven by frequent replacement needs and increasing surgical volumes.

Autotransfusion systems, including intraoperative, post-operative, and dual-mode systems, are projected to grow steadily due to rising awareness of autologous blood transfusion benefits.

By Application

Applications include cardiovascular, orthopedic, neurological, obstetrics & gynecological surgeries, and others.

The cardiovascular surgeries segment led the market, accounting for 60.11% share in 2024, due to high blood loss procedures such as CABG and valve replacements. Orthopedic surgeries held the second-largest share, while neurological and OB/GYN surgeries are expected to grow at moderate rates.

By End User

The market is divided into hospitals and specialty clinics.

The hospitals segment dominated in 2026 with an 89.67% share, supported by the high volume of major surgeries performed in hospital settings. Specialty clinics are projected to grow steadily with increasing adoption of cell salvage technologies.

Regional Insights

North America

North America accounted for USD 164.03 million in 2025 and is projected to reach USD 174.85 million in 2026. The U.S. market is expected to reach USD 160.63 million in 2026. Strong regulatory support and established blood management guidelines drive regional growth.

Europe

Europe is experiencing steady growth due to rising surgical procedures and increased awareness.

• UK market: USD 21.7 million by 2026
• Germany market: USD 32.61 million by 2026

Asia Pacific

Asia Pacific is projected to grow at a significant CAGR through 2034.

• Japan: USD 12.24 million by 2026
• China: USD 11.75 million by 2026
• India: USD 3.8 million by 2026

Expanding healthcare infrastructure and increasing hospital numbers support growth.

Rest of the World

Countries such as Brazil, Saudi Arabia, and the UAE are witnessing rising surgical volumes, contributing to steady regional growth.

Competitive Landscape

The market is highly consolidated, with key players including LivaNova PLC, Haemonetics Corporation, Fresenius SE & Co. KGaA, Medtronic, BD, Beijing Jingjing Medical Equipment Co., and ProCell Surgical Inc.

Companies are focusing on regulatory approvals, partnerships, and product innovation to strengthen their global presence.

Conclusion

The global autotransfusion devices market is set to grow from USD 329.61 million in 2025 to USD 590.49 million by 2034, driven by increasing surgical volumes, rising organ transplants, technological advancements, and the need to address blood supply shortages. North America remains the dominant region, while Asia Pacific presents strong growth opportunities. Despite challenges such as high costs and the rise of minimally invasive surgeries, continued innovation and expanding healthcare infrastructure are expected to sustain steady market expansion through 2034.

Segmentation By Product Type

• Autotransfusion Systems
  • Intraoperative Autotransfusion Systems
  • Post-operative Autotransfusion Systems
  • Dual-Mode Autotransfusion Systems
• Consumables & Accessories

By Application

• Cardiovascular Surgeries
• Orthopedic Surgeries
• Neurological Surgeries
• Obstetrics & Gynecological Surgeries
• Others

By End User

• Hospitals
• Specialty Clinics & Others

By Region

• North America (By Product Type, By Application, By End User, and By Country)
  • U.S. (By Application)
  • Canada (By Application)
• Europe (By Product Type, By Application, By End User, and By Country/Sub-Region)
  • U.K. (By Application)
  • Germany (By Application)
  • France (By Application)
  • Italy (By Application)
  • Spain (By Application)
  • Scandinavia (By Application)
  • Rest of Europe (By Application)
• Asia Pacific (By Product Type, By Technology, By End User, and By Country/Sub-Region)
  • Japan (By Application)
  • China (By Application)
  • India (By Application)
  • Australia (By Application)
  • Southeast Asia (By Application)
  • Rest of Asia Pacific (By Application)
• Rest of the World (By Product Type, By Application, By End User)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Cardiovascular Surgeries, By Key Countries, 2025
• 4.2. Number of Major Orthopedic Surgeries, By Key Countries, 2025
• 4.3. Number of Major Obstetrics & Gynecological Surgeries, By Key Countries, 2025
• 4.4. Key Industry Developments - Mergers, Acquisitions, Partnerships, and Launches
• 4.5. Impact of COVID-19 on the Market

5. Global Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast- By Product Type
  • 5.1.1. Autotransfusion Systems
    • 5.1.1.1. Intraoperative Autotransfusion Systems
    • 5.1.1.2. Postoperative Autotransfusion Systems
    • 5.1.1.3. Dual-mode Autotransfusion Systems
  • 5.1.2. Consumables & Accessories
• 5.2. Market Analysis, Insights and Forecast- By Application
  • 5.2.1. Cardiovascular Surgeries
  • 5.2.2. Orthopedic Surgeries
  • 5.2.3. Neurological Surgeries
  • 5.2.4. Obstetrics & Gynecological Surgeries
  • 5.2.5. Others
• 5.3. Market Analysis, Insights and Forecast- By End-user
  • 5.3.1. Hospital
  • 5.3.2. Specialty Clinics & Others
• 5.4. Market Analysis, Insights and Forecast- By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Rest of the World

6. North America Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Autotransfusion Systems
    • 6.1.1.1. Intraoperative Autotransfusion Systems
    • 6.1.1.2. Postoperative Autotransfusion Systems
    • 6.1.1.3. Dual-mode Autotransfusion Systems
  • 6.1.2. Consumables & Accessories
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Cardiovascular Surgeries
  • 6.2.2. Orthopedic Surgeries
  • 6.2.3. Neurological Surgeries
  • 6.2.4. Obstetrics & Gynecological Surgeries
  • 6.2.5. Others
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Hospital
  • 6.3.2. Specialty Clinics & Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
    • 6.4.1.1. By Application
  • 6.4.2. Canada
    • 6.4.2.1. By Application

7. Europe Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Autotransfusion Systems
    • 7.1.1.1. Intraoperative Autotransfusion Systems
    • 7.1.1.2. Postoperative Autotransfusion Systems
    • 7.1.1.3. Dual-mode Autotransfusion Systems
  • 7.1.2. Consumables & Accessories
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Cardiovascular Surgeries
  • 7.2.2. Orthopedic Surgeries
  • 7.2.3. Neurological Surgeries
  • 7.2.4. Obstetrics & Gynecological Surgeries
  • 7.2.5. Others
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Hospital
  • 7.3.2. Specialty Clinics & Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.4.1. U.K.
    • 7.4.1.1. By Application
  • 7.4.2. Germany
    • 7.4.2.1. By Application
  • 7.4.3. France
    • 7.4.3.1. By Application
  • 7.4.4. Spain
    • 7.4.4.1. By Application
  • 7.4.5. Italy
    • 7.4.5.1. By Application
  • 7.4.6. Scandinavia
    • 7.4.6.1. By Application
  • 7.4.7. Rest of Europe
    • 7.4.7.1. By Application

8. Asia Pacific Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Autotransfusion Systems
    • 8.1.1.1. Intraoperative Autotransfusion Systems
    • 8.1.1.2. Postoperative Autotransfusion Systems
    • 8.1.1.3. Dual-mode Autotransfusion Systems
  • 8.1.2. Consumables & Accessories
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Cardiovascular Surgeries
  • 8.2.2. Orthopedic Surgeries
  • 8.2.3. Neurological Surgeries
  • 8.2.4. Obstetrics & Gynecological Surgeries
  • 8.2.5. Others
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Hospital
  • 8.3.2. Specialty Clinics & Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.4.1. Japan
    • 8.4.1.1. By Application
  • 8.4.2. China
    • 8.4.2.1. By Application
  • 8.4.3. India
    • 8.4.3.1. By Application
  • 8.4.4. Australia
    • 8.4.4.1. By Application
  • 8.4.5. Southeast Asia
    • 8.4.5.1. By Application
  • 8.4.6. Rest of Asia Pacific
    • 8.4.6.1. By Application

9. Rest of the World Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Autotransfusion Systems
    • 9.1.1.1. Intraoperative Autotransfusion Systems
    • 9.1.1.2. Postoperative Autotransfusion Systems
    • 9.1.1.3. Dual-mode Autotransfusion Systems
  • 9.1.2. Consumables & Accessories
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Cardiovascular Surgeries
  • 9.2.2. Orthopedic Surgeries
  • 9.2.3. Neurological Surgeries
  • 9.2.4. Obstetrics & Gynecological Surgeries
  • 9.2.5. Others
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Hospital
  • 9.3.2. Specialty Clinics & Others

10. Competitive Analysis

• 10.1. Global Market Share Analysis (2025)
• 10.2. Company Profiles
  • 10.2.1. Haemonetics Corporation
    • 10.2.1.1. Overview
    • 10.2.1.2. Products & services
    • 10.2.1.3. SWOT Analysis
    • 10.2.1.4. Recent Developments
    • 10.2.1.5. Strategies
    • 10.2.1.6. Financials (Based on Availability)
  • 10.2.2. LivaNova PLC
    • 10.2.2.1. Overview
    • 10.2.2.2. Products & services
    • 10.2.2.3. SWOT Analysis
    • 10.2.2.4. Recent Developments
    • 10.2.2.5. Strategies
    • 10.2.2.6. Financials (Based on Availability)
  • 10.2.3. Medtronic
    • 10.2.3.1. Overview
    • 10.2.3.2. Products & services
    • 10.2.3.3. SWOT Analysis
    • 10.2.3.4. Recent Developments
    • 10.2.3.5. Strategies
    • 10.2.3.6. Financials (Based on Availability)
  • 10.2.4. Fresenius SE & Co. KGaA
    • 10.2.4.1. Overview
    • 10.2.4.2. Products & services
    • 10.2.4.3. SWOT Analysis
    • 10.2.4.4. Recent Developments
    • 10.2.4.5. Strategies
    • 10.2.4.6. Financials (Based on Availability)
  • 10.2.5. BD
    • 10.2.5.1. Overview
    • 10.2.5.2. Products & services
    • 10.2.5.3. SWOT Analysis
    • 10.2.5.4. Recent Developments
    • 10.2.5.5. Strategies
    • 10.2.5.6. Financials (Based on Availability)
  • 10.2.6. Beijing Jingjing Medical Equipment Co., Ltd.
    • 10.2.6.1. Overview
    • 10.2.6.2. Products & services
    • 10.2.6.3. SWOT Analysis
    • 10.2.6.4. Recent Developments
    • 10.2.6.5. Strategies
    • 10.2.6.6. Financials (Based on Availability)
  • 10.2.7. ProCell Surgical Inc.
    • 10.2.7.1. Overview
    • 10.2.7.2. Products & services
    • 10.2.7.3. SWOT Analysis
    • 10.2.7.4. Recent Developments
    • 10.2.7.5. Strategies
    • 10.2.7.6. Financials (Based on Availability)